Pain management (chronic back pain, arthritis, neuropathic pain) is the largest therapeutic use — patients take tramadol for months or years. Postoperative pain is the fastest‑growing. The tramadol drug market research study shows that postoperative use is growing at over 6% CAGR, driven by the shift toward outpatient surgery and the need for non‑opioid alternatives to morphine.

What's the difference? For postoperative pain, tramadol is usually given intravenously in the hospital, then switched to oral for home. The tramadol drug market trends highlight that the fastest‑growing route of administration is intravenous, because of enhanced recovery after surgery (ERAS) protocols.

But tramadol is not strong enough for major surgery (like joint replacement). For those, you still need traditional opioids. And for day surgeries (laparoscopic cholecystectomy), tramadol may be sufficient.

The bottom line: if you're having minor surgery, ask your anaesthesiologist about tramadol. It might be enough — and it's less likely to cause addiction.